Participants 58 99 7
women with locally advanced breast cancer
Participants 248 275 4
patients with breast cancer
Participants 415 474 3
women undergoing neoadjuvant chemotherapy for breast cancer
Participants 527 614 3
, phase 2 randomised trial between March 17, 2003, and May 19, 2006, at a single centre
Participants 616 659 10
Eligible patients had clinical stage II-III
Participants 832 841 10
120 women
Participants 1460 1584 5
120 patients initially enrolled, one withdrew after signing consent and one patient's baseline bone marrow was not available
Participants 1649 1700 3
109 bone-marrow samples were available for analysis
